Changes to the QTdrugs List and List of Drugs to Avoid in cLQTS

Members with cardiac conditions may like to consider registering with CredibleMeds to be kept up to date with any changes to the QT drugs to avoid list https://crediblemeds.org/everyone/.

We have recently received the following message through CredibleMeds:

December 12, 2023

Re: Changes to the QTdrugs List and List of Drugs to Avoid in cLQTS

Dear CredibleMeds Registrants:

AZCERT’s Scientific Review Committee has found substantial evidence that Triclabendazole (antiparasitic) is associated with the development of QT prolongation but lacks convincing evidence of torsades de pointes (TdP).  Therefore, this drug has been added to the Possible Risk of TdP category (PR) and the List of Drugs to Avoid in patients with Congenital Long QT Syndrome (DTA List).  

More to explorer

National myheart meeting-16th March,2024

A myheart members’ meeting is planned at Friends House,  173-177 Euston Road, London NW1 2BJ, between 2pm-5pm on Saturday 16th March, 2024. Registrations

Leading researchers gather at St George’s University of London, to showcase a portfolio of projects funded by Cardiac Risk in the Young

WhatsApp
Facebook
Twitter
Reddit
Email
Skip to content